| Original language | English |
|---|---|
| Article number | 497 |
| Journal | Annals of Translational Medicine |
| Volume | 4 |
| Issue number | 24 |
| DOIs | |
| State | Published - Dec 2016 |
Defensin-chemokine heteromeric complexes derived from heterocellular activation-a possible target to inhibit CCL5 in cardiovascular settings
Osamu Baba, Yongjian Liu, Gwendalyn J. Randolph
- Institute of Clinical and Translational Sciences (ICTS)
- Siteman Cancer Center
- Division of Immunobiology
- Center for the Investigation of Membrane Excitability Diseases
- Center of Regenerative Medicine
- Roy and Diana Vagelos Division of Biology & Biomedical Sciences (DBBS)
- COVID-19 Researchers
- Precision Radiotheranostics Translation Center (PRTC)
- Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs)
- DBBS - Immunology
- DBBS - Molecular Microbiology and Microbial Pathogenesis
- Brain Tumor Center
- DBBS - Molecular Cell Biology
Research output: Contribution to journal › Editorial
1
Scopus
citations